Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iopamidol SCHEMBL471484 | 1.00 | LMNA (1.00) | LMNASMN1; SMN2CYP2C19HIF1ACYP3A4 | |
| Iopamidol SCHEMBL7101453 | 1.00 | LMNA (1.00) | LMNASMN1; SMN2CYP2C19HIF1ACYP3A4 | |
| SCHEMBL22006124 | 0.96 | LMNA (0.92) | LMNASMN1; SMN2CYP2C19HIF1A | |
| Iopamidol SCHEMBL3424448 | 0.96 | LMNA (0.92) | LMNASMN1; SMN2CYP2C19HIF1A | |
| Iopamidol SCHEMBL2140144 | 0.96 | LMNA (0.92) | LMNASMN1; SMN2CYP2C19HIF1ACYP3A4 | |
| SCHEMBL31409203 | 0.95 | LMNA (0.90) | LMNASMN1; SMN2CYP2C19HIF1ACYP3A4 | |
| SCHEMBL7709204 | 0.95 | LMNA (0.90) | LMNASMN1; SMN2CYP2C19HIF1A | |
| SCHEMBL13283626 | 0.95 | LMNA (0.90) | LMNASMN1; SMN2CYP2C19HIF1A | |
| SCHEMBL22661225 | 0.92 | LMNA (0.85) | LMNASMN1; SMN2CYP2C19HIF1A | |
| SCHEMBL15297031 | 0.92 | LMNA (0.84) | LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11584 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075768-A | Degradable embolism microsphere with developing property and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-20260137558-A1 | OPHTHALMIC DEVICE | Able Tx Ltd. (IL) | 2026-05-21 | — | — | US | claimed |
| US-20260140444-A1 | PHOTORESIST COMPOSITION AND METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2026-05-21 | — | — | US | claimed |
| CN-122057065-A | Ultrasonic-triggered enzymatic crosslinking hydrogel embolic agent and preparation method thereof | 中山大学附属第五医院 | 2026-05-19 | — | — | CN | claimed |
| CN-122057084-A | Valve clamp and preparation method thereof | 科凯(南通)生命科学有限公司 | 2026-05-19 | — | — | CN | claimed |
| WO-2026101973-A1 | IODINATED MULTI-FUNCTIONAL COMPOUNDS WITH ENHANCED HYDROLYTIC STABILITY IN RADIOPAQUE HYDROGELS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| CN-122029126-A | Method for obtaining iodide ions from a solution comprising an iodine-containing aromatic compound | 伯拉考成像股份公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260125517-A1 | IODINATED MULTI-FUNCTIONAL COMPOUNDS WITH ENHANCED HYDROLYTIC STABILITY IN RADIOPAQUE HYDROGELS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-05-07 | — | — | US | claimed |
| EP-4259119-B1 | EMBOLIZING EMULSION FOR TREATMENT OF INFLAMMATORY HYPERVASCULARIZATION ASSOCIATED WITH MUSCULOSKELETAL DISORDERS | HOPITAUX PARIS ASSIST PUBLIQUE (FR) | 2026-05-06 | — | — | EP | claimed |
| US-12616681-B2 | Compositions and methods for treating renal injury | CASE WESTERN RESERVE UNIVERSITY (US) | 2026-05-05 | — | — | US | claimed |
| EP-0414288-A1 | Contrast media | NYCOMED IMAGING AS (NO) | 1991-02-27 | — | — | EP | claimed |
| EP-0412280-A2 | Fastening means | BIOVISION GmbH Entwicklung, Herstellung und Vertrieb von Biomaterialien (DE) | 1991-02-13 | — | — | EP | claimed |
| WO-1991001149-A1 | CONTRAST MEDIA | NYCOMED AS (NO) | 1991-02-07 | — | — | WO | claimed |
| WO-1990011094-A1 | CONTRAST MEDIA | NYCOMED AS (NO) | 1990-10-04 | — | — | WO | claimed |
| EP-0390242-A1 | Contrast media | NYCOMED IMAGING AS (NO) | 1990-10-03 | — | — | EP | claimed |
| CN-1045528-A | CONTRAST MEDIA | NYCOMED AS (NO) | 1990-09-26 | — | — | CN | claimed |
| WO-1989011272-A1 | HIGH RATIO ACTIVE AGENT:LIPID COMPLEX | THE LIPOSOME COMPANY, INC. (US) | 1989-11-30 | — | — | WO | claimed |
| EP-0314764-A1 | INJECTABLE OPACIFYING LIPOSOME COMPOSITION. | BRACCO IND CHIMICA SPA (IT) | 1989-05-10 | — | — | EP | claimed |
| WO-1988009165-A1 | INJECTABLE OPACIFYING LIPOSOME COMPOSITION | BRACCO INDUSTRIA CHIMICA S.P.A. (IT) | 1988-12-01 | — | — | WO | claimed |
| EP-0128578-A1 | Ethanolic suspensions of contrast agents | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 1984-12-19 | — | — | EP | claimed |